Preclinical News and Research

RSS
p53 protein may show a typical prion-like behavior when mutated

p53 protein may show a typical prion-like behavior when mutated

KaloBios’ KB001 shows promise against Pa pneumonia

KaloBios’ KB001 shows promise against Pa pneumonia

Intensive insulin may backfire in acute stroke

Intensive insulin may backfire in acute stroke

Enrollment commences in Stealth Peptides' Bendavia Phase II clinical study for acute STEMI

Enrollment commences in Stealth Peptides' Bendavia Phase II clinical study for acute STEMI

UC3M joins European research project on tuberculosis treatments

UC3M joins European research project on tuberculosis treatments

KPT-SINEs might offer new treatment for people with acute leukemia

KPT-SINEs might offer new treatment for people with acute leukemia

Covidien introduces knotless suturing device for laparoscopic surgery

Covidien introduces knotless suturing device for laparoscopic surgery

AstraZeneca, Rigel enter global license agreement for R256 inhaled JAK inhibitor to treat chronic asthma

AstraZeneca, Rigel enter global license agreement for R256 inhaled JAK inhibitor to treat chronic asthma

FORMA, TD2 leverage synergistic capabilities to jointly develop transformative cancer therapies

FORMA, TD2 leverage synergistic capabilities to jointly develop transformative cancer therapies

Implanted device delivers genetically engineered neurotrophic factor directly to the brain

Implanted device delivers genetically engineered neurotrophic factor directly to the brain

Study on identification of novel stem cell population in neuroblastoma to be presented at ANR conference

Study on identification of novel stem cell population in neuroblastoma to be presented at ANR conference

Zealand Pharma, Protagonist partner to develop novel disulfide-rich peptides

Zealand Pharma, Protagonist partner to develop novel disulfide-rich peptides

Wellcome Trust awards University of Maryland $4M to accelerate development of conjugate NTS vaccine

Wellcome Trust awards University of Maryland $4M to accelerate development of conjugate NTS vaccine

Infinity voluntarily stops saridegib Phase 2 trial for chondrosarcoma

Infinity voluntarily stops saridegib Phase 2 trial for chondrosarcoma

Ascepion, Debiopharm partner to develop and commercialize ASP-08126 for solid tumors

Ascepion, Debiopharm partner to develop and commercialize ASP-08126 for solid tumors

Positive results from ERYTECH Pharma asparaginase Phase II trials on ALL

Positive results from ERYTECH Pharma asparaginase Phase II trials on ALL

iPS Academia Japan, Life Technologies partner for induced pluripotent stem cell patent portfolio

iPS Academia Japan, Life Technologies partner for induced pluripotent stem cell patent portfolio

NextGen commercializes new assay for identification of biomarkers in brain disorders

NextGen commercializes new assay for identification of biomarkers in brain disorders

DFINE completes initial phase of STAR Tumor Ablation System trial

DFINE completes initial phase of STAR Tumor Ablation System trial

Bruker inaugurates new applications and customer support Center of Excellence in Moscow

Bruker inaugurates new applications and customer support Center of Excellence in Moscow

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.